Evidence map›Paper›PMID 37101788›Full record

ReviewPeerJ2023

Myriad applications of bacteriophages beyond phage therapy.

Juan Carlos García-Cruz, Daniel Huelgas-Méndez, Jorge Santiago Jiménez-Zúñiga, Xareni Rebollar-Juárez, Mariel Hernández-Garnica, Ana María Fernández-Presas, Fohad Mabood Husain, Rawaf Alenazy, Mohammed Alqasmi, Thamer Albalawi and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. A LyticInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  12. Article
  13. Immunomodulatory Effects ofBiomedicines · 2025
    Article
  14. Review
  15. Phagetherapy updates: New frontiers against antibiotic resistance.European journal of microbiology & immunology · 2025
    Review
  16. Review
  17. Review
  18. Harnessing phages to tackle antimicrobial resistance: a Saudi Arabian perspective.Frontiers in cellular and infection microbiology · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Juan Carlos García-Cruz *Faculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.
Daniel Huelgas-Méndez *Faculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.
Jorge Santiago Jiménez-ZúñigaFaculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.
Xareni Rebollar-JuárezFaculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.
Mariel Hernández-GarnicaFaculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.
Ana María Fernández-PresasFaculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.
Fohad Mabood HusainDepartment of Food Science and Nutrition, King Saud University, Riyadh, Saudi Arabia.
Rawaf AlenazyDepartment of Medical Laboratory, College of Applied Medical Sciences-Shaqra, Shaqra University, Shaqra, Saudi Arabia.
Mohammed AlqasmiDepartment of Medical Laboratory, College of Applied Medical Sciences-Shaqra, Shaqra University, Shaqra, Saudi Arabia.
Thamer AlbalawiDepartment of Biology, Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia.
Pravej AlamDepartment of Biology, Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia.
Rodolfo García-ContrerasFaculty of Medicine Department of Microbiology and Parasitology, Universidad Nacional de México, Mexico City, Mexico.ORCID 0000-0001-8475-2282
Universidad Nacional Autónoma de México · MXPrince Sattam Bin Abdulaziz University · SAShaqra University · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages are the most abundant biological entity on the planet, having pivotal roles in bacterial ecology, animal and plant health, and in the biogeochemical cycles. Although, in principle, phages are simple entities that replicate at the expense of their bacterial hosts, due the importance of bacteria in all aspects of nature, they have the potential to influence and modify diverse processes, either in subtle or profound ways. Traditionally, the main application of bacteriophages is phage therapy, which is their utilization to combat and help to clear bacterial infections, from enteric diseases, to skin infections, chronic infections, sepsis,

Indexed as

Bacterial InfectionsBacteriophagesPhage TherapyAnimalsBacteriaBacteriophageDisinfectantsDysbiosisGlobal warmingPestResistanceVirulence

Identifiers

PMID37101788
PMCPMC10124553
OpenAlexW4366688199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.